Article
The efflux of anthracyclines in multidrug-resistant cell lines.
Biochemical pharmacology - 19 Oct 1993
Coley H M, Twentyman P R, Workman P
Abstract excerpt
In order to address the association of enhanced drug efflux with the multidrug-resistant (MDR) phenotype, we have studied the cellular pharmacokinetics of anthracyclines in the P-glycoprotein (Pgp)-positive MDR cell lines H69/LX4 (human small cell lung cancer) and EMT6/AR1.0 (mouse mammary tumour). Both doxorubicin (DOX) and daunorubicin (DNR) were accumulated to a lesser extent and effluxed at a higher rate by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
